SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Barosi G.)
 

Sökning: WFRF:(Barosi G.) > A unified definitio...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003305naa a2200529 4500
001oai:DiVA.org:uu-24970
003SwePub
008070208s2007 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-249702 URI
024a https://doi.org/10.1038/sj.leu.24044732 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Barosi, G.4 aut
2451 0a A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia :b results of a consensus process by an international working group
264 c 2006-11-16
264 1b Springer Science and Business Media LLC,c 2007
338 a print2 rdacarrier
520 a A widely accepted definition of resistance or intolerance to hydroxyurea (HU) in patients with essential thrombocythemia (ET) is lacking. An international working group (WG) was convened to develop a consensus formulation of clinically significant criteria for defining resistance/intolerance to HU in ET. To this aim, an analytic hierarchy process (AHP), a multiple-attribute decision-making technique, was used. The steps consisted of selecting the candidate criteria for defining resistance/intolerance; identifying the motivations that could influence the preference of the WG for any individual criterion; comparing the candidate criteria in a pair-wise manner; and grading them according their ability to fulfill the motivations. Every step in the model was derived by questionnaires or group discussion. The WG proposed that the definition of resistance/intolerance should require the fulfillment of at least one of the following criteria: platelet count greater than 600,000/micro l after 3 months of at least 2 g/day of HU (2.5 g/day in patients with a body weight over 80 kg); platelet count greater than 400,000/micro l and WBC less than 2500/micro l or Hb less than 10 g/dl at any dose of HU; presence of leg ulcers or other unacceptable muco-cutaneous manifestations at any dose of HU; HU-related fever.
653 a essential thrombocythemia
653 a hydroxyurea
653 a analytic hierarchy process
653 a resistance
653 a intolerance
653 a MEDICINE
653 a MEDICIN
700a Besses, C.4 aut
700a Birgegård, Gunnar,d 1944-u Uppsala universitet,Institutionen för medicinska vetenskaper,Hematologi4 aut0 (Swepub:uu)gunnarbg
700a Briere, J.4 aut
700a Cervantes, F.4 aut
700a Finazzi, G.4 aut
700a Gisslinger, H.4 aut
700a Griesshammer, M.4 aut
700a Gugliotta, L.4 aut
700a Harrison, C.4 aut
700a Hasselbalch, H.4 aut
700a Lengfelder, E.4 aut
700a Reilly, J. T.4 aut
700a Michiels, J. J.4 aut
700a Barbui, T.4 aut
710a Uppsala universitetb Institutionen för medicinska vetenskaper4 org
773t Leukemiad : Springer Science and Business Media LLCg 21:2, s. 277-280q 21:2<277-280x 0887-6924x 1476-5551
856u https://www.nature.com/articles/2404473.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-24970
8564 8u https://doi.org/10.1038/sj.leu.2404473

Hitta via bibliotek

  • Leukemia (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy